12.07.2015 Views

Bariatric treatments for adult obesity - Institute of Health Economics

Bariatric treatments for adult obesity - Institute of Health Economics

Bariatric treatments for adult obesity - Institute of Health Economics

SHOW MORE
SHOW LESS
  • No tags were found...

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Result<strong>Health</strong> outcomesCostsMarginal analysisConclusionOf a total <strong>of</strong> 401 participants, 243 were in dietician group and 158 in GP group; 377 werewithout IHD (243 in GP group and 134 in dietician group).Life years gained: 0.0274 versus 0.0919 in dietician versus GP group; 0.0919 versus 0.1608<strong>for</strong> those without IHDTotal costs: Dkr 1642 versus 755 in dietician versus GP groupCompared with no counselling, the ICER was Dkr 8,213 and Dkr 59,987 per LY gainedin GP and dietician group, respectively; <strong>for</strong> patients without IHD, ICER decreases to Dkr4670 and Dkr 23,469, respectively.Nutritional counselling by a GP or a dietician was cost-effective <strong>for</strong> obese patients with ahigh risk <strong>of</strong> IHD. Intervention by a GP was superior to that by a dietician.4 Study 24 Authors/publish year: Malone /2005; country: US; study type: CEA; setting: secondarycare; study perspective: payerObjectiveTo assess the cost-effectiveness <strong>of</strong> sibutramineplus a WMP <strong>for</strong> overweight and obesepatients.Population Individuals aged 18 years or older with a BMI ≥ 30 kg/m 2 or a BMI <strong>of</strong> 27 kg/m 2 to 29.9kg/m 2 with one or more co-morbidities, including diabetes, hypertension, orhyperlipidaemia.InterventionTime Horizon/discount rateCurrency/priceyearResult<strong>Health</strong> outcomesCostsSibutramine plus a WMP was compared with WMP alone. The WMP was a physiciansupervised,multidisciplinary program, including five monitored care visits.12 months/NAUS$/2004Of 501 patients included in the study, 281 were randomized to the intervention group and220 to the control group (WMP alone). The groups were not comparable in terms <strong>of</strong>patient demographics and BMI at baseline.In the intervention versus control group, the mean weight loss at 12 months was 13.7versus 5 pounds; per cent change in weight was -6% versus -2.2%; and per cent havingweight loss <strong>of</strong> at least 10% was 19.6% versus 10%.The median increase in total costs from 12 months be<strong>for</strong>e enrolment to 12 months afterenrolment was $1279 in the intervention group and $271 in the control group; the medianincrease in <strong>obesity</strong>-related costs was $408 versus $31 in both groups.Marginal analysisConclusionWhen total costs were considered, the mean ICER <strong>of</strong> intervention over control groupwas $194 per additional pound reduced; $399 per percentage change in weight loss.When <strong>obesity</strong>-related costs were considered, the mean ICER <strong>of</strong> intervention over controlgroup was $44 per additional pound reduced; $101 per percentage change in weight loss.Adding sibutramine to a WMP led to a significantly greater reduction in weight, but nosavings in costs.<strong>Bariatric</strong> <strong>treatments</strong> <strong>for</strong> <strong>adult</strong> <strong>obesity</strong> 188

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!